Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Pancreatic Neoplasms × Valacyclovir × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pleural Effusion, Malignant 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Mesothelioma 1 Lung Neoplasms 1 Glioma 1 Glioblastoma 1 Breast Neoplasms 1 Brain Neoplasms 1 Astrocytoma 1

Interventions

Gemcitabine 138 130-nm albumin-bound paclitaxel 44 Albumin-Bound Paclitaxel 33 pembrolizumab 28 Capecitabine 28 Oxaliplatin 27 Fluorouracil 26 Radiotherapy 23 Irinotecan 23 Leucovorin 22 Erlotinib Hydrochloride 21 Nivolumab 19 Cisplatin 17 Taxes 16 Bevacizumab 13 Radiosurgery 11 Cyclophosphamide 11 Specimen Handling 10 Carboplatin 10 Magnetic Resonance Spectroscopy 9 Docetaxel 9 Paclitaxel 8 Ipilimumab 8 trametinib 7 poly ICLC 7 olaparib 7 fludarabine 7 Sorafenib 7 Cetuximab 7 Biopsy 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00638612 2023-08-25

PaTK01

Candel Therapeutics, Inc.

Phase 1 Completed

Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡